What is the highest mg of Ambien

Zolpidem affects driving ability

Somnologists warn, however, against evaluating the short-term use of zolpidem too critically, as a "hang-over effect" is typical for many psychotropic drugs, but failure to treat sleep disorders due to the subsequent reduction in vigilance affects the ability to drive much more. Therefore, in Germany, a demand for individually coordinated drug doses is more likely to be supported. The benzodiazepine analogs are considered to be on an equal footing with the benzodiazepines in terms of their addiction potential. Therapy should therefore begin with a quarter to half a tablet and only increase to the dose that the patient needs, so that the potential for dependence is low. The duration of treatment should be as short as possible; In general, the intake should only last a few days to around two weeks or, including the gradual withdrawal phase, not exceed four weeks.


[1] FDA drug safety communication: risk of next-morning impairment after use of insomnia drugs; FDA requires lower recommended doses for certain drugs containing zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist) www.fda.gov/Drugs/DrugSafety/ucm334033.htm

[2] FDA drug safety communication: FDA approves new label changes and dosing for zolpidem products and a recommendation to avoid driving the day after using Ambien CR (www.fda.gov/Drugs/DrugSafety/ucm352085.htm)

[3] EMA, Review of zolpidem-containing medicines started (www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Zolpidem containing_medicines / human_referral_prac_000030.jsp & mid = WC0b01ac05805c516f)


Pharmacist André Said